Details for 2016816363
Up to date per 01.04.2026
Actions
Details for 2016816363
Granted/Registered
European Patent
24.10.2018 A
09.09.2020 B1
16.12.2015
GB
201522245
15.08.2016
GB
201613945
C07D 405/14 20060101AFI20170718BHEP
Owner
Loxo Oncology, Inc.Lilly Corporate Centre Indianapolis Indiana 46285US
Representative
Representative
Schwarz & Partner Patentanwälte GmbHWipplingerstraße 301010 WienAT
Inventor
GUISOT, Nicolasc/o Redx Pharma PLC Block 33F Mereside Alderley Park Alderley Edge Cheshire SK10 4TGGB
Information about Fees